CLAL Biotechnology Industries Ltd. Logo

CLAL Biotechnology Industries Ltd.

A life sciences VC firm financing and supporting innovative biotech & healthcare ventures.

CBI | TA

Overview

Corporate Details

ISIN(s):
IL0011042806
LEI:
Country:
Israel
Address:
Triangle Building 45th flr., 67023 Tel Aviv
Sector:
Financial and insurance activities
Industry:
Other financial service activities, except insurance and pension funding activities

Description

Clal Biotechnology Industries Ltd. (CBI) is a leading life sciences investment company and venture capital firm founded in 1998. CBI specializes in identifying, financing, and supporting innovative ventures within the biotechnology and healthcare sectors. Its investment strategy focuses on biopharmaceutical, diagnostic, and medical device companies that develop proprietary solutions to address significant unmet medical needs with high market potential. The firm actively manages its portfolio companies, providing strategic support to foster their growth from early-stage development through to commercialization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-01-08 10:01
Investor Presentation
Corporate Presentation, January 2023
English 3.1 MB
2023-01-08 10:01
Regulatory News Service
Corporate Presentation, January 2023
Russian 41.8 KB
2021-02-14 15:58
Investor Presentation
CBI-Presentation-February 2021
English 2.4 MB
2021-02-14 15:58
Pre-Annual General Meeting Information
CBI-Presentation-February 2021
Russian 43.2 KB
2020-11-22 11:19
Investor Presentation
INVESTORS PRESENTATION,NOVEMBER 10,2020
English 1.9 MB
2020-11-22 11:19
Post-Annual General Meeting Information
INVESTORS PRESENTATION,NOVEMBER 10,2020
Russian 43.3 KB
2020-08-24 11:54
Investor Presentation
CORPORATE PRESENTATION AUGUST 2020
English 1.7 MB
2020-08-24 11:54
Regulatory News Service
CORPORATE PRESENTATION AUGUST 2020
Russian 43.2 KB

Automate Your Workflow. Get a real-time feed of all CLAL Biotechnology Industries Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CLAL Biotechnology Industries Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Acquires & resolves non-performing loans with flexible payment plans for debtors.
Türkiye EMIRV
ESCORT TEKNOLOJİ YATIRIM A.Ş. Logo
A technology investment firm funding high-growth startups in SaaS, IoT, biotech, and renewable energy.
Türkiye ESCOM
ESG Core Investments B.V. Logo
SPAC acquiring a high-growth, ESG-focused business in Northwestern Europe.
Netherlands ESG
Eurazeo SE Logo
A global private markets investor in equity, debt & real assets, funding startups to mid-caps.
France RF
EUROPEAN GREEN TRANSITION PLC Logo
Invests in undervalued European green economy assets via M&A to generate shareholder returns.
United Kingdom EGT
Europejski Fundusz Energii Spolka Akcyjna Logo
Private equity firm investing in renewable energy, medical, and ecological ventures.
Poland EFE
EURO Ressources S.A. Logo
A precious metals royalty company with its principal asset in a Suriname gold mine.
France EUR
EUWAX AG Logo
A liquidity provider and broker for multi-asset trading on European stock exchanges.
Germany EUX
Investment firm acquiring mining & exploration opportunities in Botswana for base & industrial minerals.
United Kingdom N/A
FANDANGO HOLDINGS PLC Logo
An investment vehicle that acquires businesses to build value and deliver shareholder returns.
United Kingdom FHP

Talk to a Data Expert

Have a question? We'll get back to you promptly.